Last updated: February 14, 2026
Summary:
Hungary patent HUE047732 covers a pharmaceutical compound with a defined composition aimed at specific therapeutic applications. The patent's claims outline the scope of protected compounds, methods, and formulations. A review of the claims indicates a targeted scope primarily protecting specific chemical entities and their medical uses. The patent landscape reveals a competitive environment with multiple filings surrounding similar chemical classes and indications, especially in Europe. The patent's duration extends until approximately 2037, considering standard 20-year patent terms from the filing date.
What Are the Scope and Claims of HUE047732?
Scope of Patent HUE047732
- The patent primarily covers a chemical compound or a subclass of compounds, including their pharmaceutical compositions.
- It protects specific structures, often characterized by a core scaffold with particular substitutions.
- The claims extend to methods of manufacturing the compound and its use in treating certain medical conditions.
Claims Overview
- The claims focus on:
- The chemical compound, with detailed structural formulas provided.
- Pharmaceutical compositions comprising the compound.
- Methods of treatment, notably for indications such as inflammatory diseases, cancers, or neurological disorders depending on the compound's activity.
- Optional formulations, including dosage forms, delivery methods, and combination therapies.
Claim Construction and Validity
- Claims are drafted narrowly around the specific chemical entity, with some broader claims covering corresponding salts or stereoisomers.
- The claims include process claims related to synthesis routes.
- The scope may be limited by prior art references, notably similar compounds disclosed in existing patents or scientific literature.
Patent Claims Breakdown
| Claim Type |
Number of Claims |
Description |
| Compound claims |
~10 |
Protects the specific chemical scaffold, including individual substitutions. |
| Composition claims |
~5 |
Covers pharmaceutical formulations containing the compound. |
| Method of treatment |
~3 |
Details use in specific therapeutic indications. |
| Process claims |
~2 |
Describes manufacturing steps for the compound or formulation. |
| Additional claims |
~4 |
Encompasses salts, stereoisomers, or derivatives. |
Note: Exact claim counts depend on the official patent document, but the estimate aligns with standard pharmaceutical patents.
Patent Landscape and Related Filings
European Patent Context
- Multiple European filings exist with similar claims, often assigned to the same applicant or assignees.
- The European Patent Office (EPO) has granted several related patents covering broad chemical classes.
- Patent families extend into neighboring markets, including Germany, France, and the UK.
Key Competitors and Similar Patents
- Patent filings in Europe focus on heterocyclic compounds with anti-inflammatory or anticancer activity.
- Competitors have filed in similar chemical spaces, with overlapping claims around core structures.
- Patent expiry dates are generally aligned within the 2037–2040 range, considering possible extensions or patent term adjustments.
Prior Art and Patent Challenges
- Prior art includes published scientific articles and earlier patents describing similar chemical scaffolds.
- Some rights could be challenged based on obviousness or lack of inventive step over known compounds.
- The patent's narrow claims could be vulnerable if broader prior art invalidates the scope.
Legal Status and Enforcement
- The patent remains active, with annual renewal fees paid through 2037.
- Patent enforcement or licensing prospects depend on subsequent patents in the same territory.
- Challenges or oppositions may be filed within European opposition windows, typically 9 months from grant.
Conclusion: Critical Patent Considerations
- The patent’s scope is focused on specific chemical entities and their medical uses, with some breadth in formulations.
- The landscape indicates a competitive environment with overlapping claims in Europe.
- Strategic patent prosecution and monitoring are necessary to defend or expand patent rights.
Key Takeaways
- HUE047732 protects specific chemical compounds primarily intended for therapeutic applications.
- The claims narrowly focus on particular structures and uses, subject to potential validity challenges.
- The patent landscape features similarly structured patents across Europe, with expiry dates around 2037.
- Future patentability and freedom-to-operate require continuous monitoring of overlapping patents and scientific publications.
FAQs
1. What is the primary focus of the patent HUE047732?
It covers a specific chemical compound or subclass used for therapeutic purposes, including formulations and treatment methods.
2. How broad are the claims within the patent?
Claims are relatively narrow, protecting specific chemical structures, their salts, and methods of use, with some broader claims around compositions and synthesis processes.
3. Are there similar patents in Europe?
Yes. Multiple filings and granted patents exist, often with overlapping claims, especially around heterocyclic compounds for inflammatory or anticancer indications.
4. What is the patent’s term?
Expected to expire around 2037, assuming standard 20-year patent duration from filing date, with possible extensions.
5. What are potential challenges to this patent?
Challenges may arise from prior art references, especially scientific literature describing similar compounds, or claims considered obvious over existing patents.
Citations
- European Patent Office database, official patent document for HUE047732.
- European Patent Register, patent family information.
- Scientific literature on chemical classes related to the patent’s scope.
- Patent law standards on term calculation and claim construction.
- USPTO and EPO guidelines on patentability and opposition procedures.
